Did you know that nearly half of adults struggle with swallowing pills? This problem affects adults of all ages, leading to missed doses or avoiding treatment. Our innovative liquid oral suspension makes medications easier to take. Learn more: https://t.co/zCKQfZQjIG
Our CEO & Founder, Michael Demurjian, was recently featured on the BioBreakthroughs podcast with @SliceofHC, where he dove into how Aspargo is transforming drug delivery! Learn how we're disrupting how medicines are formulated, delivered and experienced: https://t.co/nrkew8sWFb
This #MensHealthMonth, spontaneity matters. At @AspargoLabs, we believe men want health options that are fast-acting and quickly adaptable, like our oral suspension of sildenafil citrate (HEZKUE®, BANDOL®), which starts working in as little as 5 minutes: https://t.co/v1JsQ2bgvJ
Men’s health too often goes undiscussed until it’s too late. We believe men deserve better. HEZKUE is our first step: a discreet, effective ED treatment that works in the moment.
This #MensHealthWeek, let’s normalize the conversation.
For more: https://t.co/xWrGXVNgX2
Michael Demurjian, CEO, joins top industry experts at #AUA2025 this Friday in Vegas. His panel “The Good, the Bad and the Ugly” promises valuable insights for investing in healthcare innovation.
For more: https://t.co/cbHJRxALx4
#Urology#AspargoLabs#ErectileDysfunction #EDSolutions
🎰CEO @Michael Demurjian heads to #AUA2025 on Friday, April 25 to participate alongside top industry leaders in a panel discussing the highs and lows of securing investments. Don’t miss out on this ace of a conversation!
For more details: https://t.co/8comqmtbSC
As we continue to enter additional markets across Europe, we’re excited to announce the appointments of Jamel Benkreira as General Manager, United Kingdom & Ireland; and Dr. Pallav S. Shah as Director of Regulatory Affairs, Europe.
Both Jamel and Pallav will be instrumental to our commercialization efforts and helping Aspargo continue to reformulate the world’s most meaningful medications into liquid oral suspensions.
https://t.co/OmhunXOrRS
#Leadership #ErectileDysfunction #EDsolutions #Growth #MedTech #GlobalMarkets
We are thrilled to announce that we will be at Europe’s biggest and most influential urological event, the 40th Annual EAU Congress. This prestigious conference is where the field’s top minds converge, bringing together leading experts and innovators in urology, and we’re honored to be part of the conversation.
See you in Madrid! #EAU25 #Urology #Innovation #Healthcare #AspargoLabs
Aspargo is growing strong in Germany! Our newest sales team has completed onboarding and we're ready to make waves across the country. With our innovative liquid sildenafil and a dedicated team on the ground, we’re excited to bring HEZKUE to even more patients.
#AspargoLabs #Liquidsildenafil #EretileDysfunction #MarketExpansion #EmergingMarkets #BusinessGrowth
Say goodbye to the worry of whether your loved one took their medication. Our digitally connected device will work seamlessly with our liquid oral suspensions, enabling real-time adherence tracking and keeping family members informed.
Learn more in @BioWorld: https://t.co/axA3DupY0K
#MedTech #DrugDelivery
Excited to share insights from our CEO, Michael Demurjian, on the future of medication delivery in @PharmExec. He discusses transforming pills into liquid forms—offering faster absorption, better bioavailability, and improved patient adherence.
At Aspargo, we’re shaping the future of drug delivery.
Read more: https://t.co/7e2u9KcALg
#PharmaInnovation #PharmaExec #AspargoLabs #LiquidSuspension
As Aspargo scales up its pipeline and product offerings, we’re thrilled to announce the appointment of Mario Guralnik, Ph.D., an expert in regulatory affairs and product development, as Chief Regulatory Officer. Dr. Guralnik’s approach will bring our products to market faster, more affordably, and with less risk.
https://t.co/DMebesFGXA
#CRO #Leadership #ErectileDysfunction #EDsolutions #MedTech
Aspargo is in Vienna for #ESSM2025 (Feb 20-22), connecting with top experts in sexual medicine and discussing the latest in research & treatment.
Excited to showcase HEZKUE®, our liquid oral sildenafil with 5 minute absorption, offering a new approach to ED treatment.
#AspargoLabs #Innovation #LiquidSildenafil
This week, we’re at #GUA25 in La Coruña, alongside the leading urologists and andrologists in Spain. Our KOLs will be speaking on the benefits of oral liquid sildenafil. We’re excited to showcase HEZKUE® and engage in insightful conversations at our booth! #AspargoLabs #ErectileDysfunction #CRU25
We're thrilled to welcome Harold D. Tamayo as our new #CFO. With 20+ years in international financial management, he will drive our financial strategy as we prepare to enter the #publicmarkets. His expertise will help advance our oral suspension technology
https://t.co/VZI4jVNIK6
Aspargo Labs at #JPM25! We're transforming the world's most meaningful medications with our innovative liquid oral suspensions. We are at a pivotal moment in our journey, and we’re excited to continue to collaborate with forward-thinking leaders. #HealthcareInnovation#MedTech
We are thrilled to announce the appointment of two highly experienced executives to accelerate Aspargo Labs’ global expansion: Álvaro Fernández – Spain and Dr. Marc van Unen – Germany.
https://t.co/kfwmVzx6YO
#News#Leadership#MarketExpansion#ErectileDysfunction
Aspargo Labs is proud to announce the appointment of Andrew Chamlin, a veteran of the health and wellness industry, as the company’s Chief Marketing Officer.
See the full release here: https://t.co/wf8EgrUR2O
#CMO#Leadership#ExecutiveAppointment
Aspargo Laboratories, Inc. Acquires International Rights to Sildenafil Oral Spray for the Treatment of Erectile Dysfunction. Click here for full press release: https://t.co/4DghusksJF